Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Dapagliflozin [undo]
  • Πέψη DNA με Περιοριστικές Ενδονουκλεάσες: Επιλογή του Κατάλληλου Ενζύμου [undo]
  • EEG [undo]
  • Node 3: Address each concern in detail [undo]
  • He is aggressive and doesn’t want to introduce himself. [undo]
  • Ei vor cumpăra o mașină. [undo]
  • Dominant and recessive [undo]
  • Genotype [undo]
  • Θάνατος [undo]
  • ΝΑ ΠΑΕΙ ΣΤΟ ΣΠΙΤΙ ΤΟΥ [undo]
  • Molecular Cloning [undo]
  • Χορήγηση πενικιλίνης, μόνο. [undo]
  • Carbimazole [undo]
  • >δεν θα αλλάξει [undo]
  • Metformin [undo]
  • Ei nu cumpără mobilă. [undo]
  • Πίνακας Punnett 2 [undo]
  • ΝΑ ΕΞΕΤΑΣΤΕΙ ΑΠΟ ΠΑΘΟΛΟΓΟ [undo]
  • Προσπαθεί να μειώσει την κατανάλωση αλκοόλ [undo]
  • To protect our clothes underneath. White matches with any skin colour tone [undo]
  • Βρογχοσκόπηση [undo]
  • Sugere convidá-los para ir a sua casa. [undo]
  • Κάνει μόνο ψυχοθεραπεία [undo]
  • Διπλοειδές και Απλοειδές [undo]
  • Κλινική εξέταση [undo]
  • Προτείνεις να δώσεις χρήματα από τον κουμπαρά σου. [undo]
  • Answer 3 [undo]
  • Απάντηση 3 [undo]
  • Επιλογή 3 [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway